Generic name: LATANOPROSTENE BUNOD 0.24mg in 1mL
Dosage form: ophthalmic solution
Medically reviewed on June 11, 2018.
The recommended dosage is one drop in the conjunctival sac of the affected eye(s) once daily in the evening. Do not administer VYZULTA™ (latanoprostene bunod ophthalmic solution), 0.024% more than once daily since it has been shown that more frequent administration of prostaglandin analogs may lessen the intraocular pressure lowering effect.
If VYZULTA is to be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure, administer each drug product at least five (5) minutes apart.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Vyzulta (latanoprostene bunod ophthalmic)
- Vyzulta Side Effects
- During Pregnancy
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: ophthalmic glaucoma agents